13 December 2022
Ropes & Gray Advises ImmunoGen in Clinical Collaboration with Gilead for Blood Cancer Combination Therapy
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Abigail Gregor Lead | Ropes & Gray | Partner | life sciences | Not stated |
| David Peloquin | Ropes & Gray | Partner | health care | Not stated |
| Mike Tentilucci | Ropes & Gray | Associate | Not stated | Not stated |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- Not stated
- What the figure measures
- Not stated
- Client
- ImmunoGenJoint venture party
- Counterparties
- Gilead Sciences (Joint venture party)